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Abstract
Background: Cardiovascular risk associated with diabetes may be partially attributed to left
ventricular structural abnormalities. However, the relations between left ventricular structure and
diabetes have not been extensively studied in African-Americans.
Methods: We studied 514 male and 965 female African-Americans 51 to 70 years old, in whom
echocardiographic left ventricular mass measurements were collected for the ARIC Study. In these,
we investigated the independent association of diabetes with left ventricular structural
abnormalities.
Results: Diabetes, hypertension and obesity prevalences were 22%, 57% and 45%, respectively.
Unindexed left ventricular mass was higher with diabetes in both men (238.3 ± 79.4 g vs. 213.7 ±
58.6 g; p < 0.001) and women (206.4 ± 61.5 g vs. 176.9 ± 50.1 g; p < 0.001), respectively. Prevalence
of height-indexed left ventricular hypertrophy was higher in women while increased relative wall
thickness was similar in men and women. Those with diabetes had higher prevalences of height-
indexed left ventricular hypertrophy (52% vs. 32%; p < 0.001), and of increased relative wall
thickness (73% vs. 64%; p = 0.002). Gender-adjusted associations of diabetes with left ventricular
hypertrophy (OR = 2.29 95%CI:1.79–2.94) were attenuated after multiple adjustments in logistic
regression (OR = 1.50 95%CI:1.12–2.00). Diabetes was associated with higher left ventricle
diameter (OR = 2.13 95%CI:1.28–3.53) only in men and with higher wall thickness (OR = 1.89
95%CI:1.34–2.66) only in women. Attenuations in diabetes associations were frequently seen after
adjustment for obesity indices.
Conclusion: In African-Americans, diabetes is associated with left ventricular hypertrophy and,
with different patterns of left ventricular structural abnormalities between genders. Attenuation
seen in adjusted associations suggests that the higher frequency of structural abnormalities seen in
diabetes may be due to factors other than hyperglycemia.
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Left ventricular hypertrophy (LVH) is frequent in diabetic
patients [1,2]. and has been identified as a powerful
marker of impaired prognosis in cardiovascular disease
[3], including in African-Americans [4].
Alterations in left ventricular (LV) structure have been
linked to diabetes but also to a large number of related
conditions such as aging, hypertension, obesity, central
obesity, dyslipidemia, salt intake, and physical inactivity
[5-7] Hence, the underlying processes common to the
coexistent risk factors, as opposed to hyperinsulinemia or
hyperglycemia, per se, may explain much of the associa-
tion seen between diabetes and LV structural abnormali-
ties.
African-Americans have a high prevalence of left ventricu-
lar structural abnormalities [8] and of its clinical corre-
lates, frequently presented together [9,10] However, few
population-based studies have adequately studied the
relations between diabetes and these structural adaptive
responses in African-Americans [11], which may have dis-
tinct pathophysiologic mechanisms [12], and also may
differ between genders [13].
This study evaluates the independent cross-sectional asso-
ciations of diabetes with LV structural alterations in a
community-based sample of African-Americans with a
high prevalence of other known risk factors for LVH.
Methods
The ARIC Study is a prospective study designed to investi-
gate the etiology and natural history of CVD in four U.S.
communities. The study design and procedures, including
the echocardiography protocol, have been previously
reported [14,15]. Between 1987 and 1989, ARIC enrolled
individuals 45 to 64 years old, and requested participants
to return for clinical visits every three years through 1998.
The initial Jackson (MI) center cohort consisted of 3728
African-Americans. Of these, echocardiography studies
were performed in 863 men and 1571 women between
1993 and 1996. We excluded those with one or more of
the following criteria: inadequate M-mode measurements
(n = 549), clinically (n = 62) or echocardiographically (n
= 212) diagnosed prevalent cardiovascular disease, and
missing covariates (n = 132), leaving 1479 participants for
analysis.
Diabetes was defined as a participant report of physician
diagnosis or diabetic medication use, fasting glucose ≥
126 mg/dL, or casual glucose ≥ 200 mg/dL. Hypertension
was defined as a mean of two separate measures greater
than 140/90 mmHg or antihypertensive drug use. Obesity
was defined as a body mass index ≥ 30 kg/m2. Body sur-
face area (BSA) was calculated as BSA = 0.007184 * weight
[kg]0.425 * height [cm]0.725, according to the Dubois for-
mula [16]. Waist-hip ratio was calculated from measure-
ments of waist (measured at the umbilicus) and hip
(measured at maximum gluteal protrusion) circumfer-
ences.
The two-dimensional guided M-mode echocardiographic
tracings were acquired with an Acuson 128XP/10c System.
Images were digitized and analyzed off-line with a com-
mercially available program. Only frames with optimal
visualization of interfaces that simultaneously showed the
interventricular septum, LV internal diameter, and poste-
rior wall were used for readings. Tracings were read by one
of two cardiologists, unaware of subject's clinical data,
and the average value from 3 measurements was com-
puted. LV mass was calculated using M-mode tracings
according to American Society of Echocardiography con-
ventions [17] and Devereux modified cubed formula [18].
To account for gender and body size variations we
indexed LV mass employing height2.7, with a boundary of
51 g/m2.7 to define LVH in both genders [19]. The intra-
and intersonographer correlations for LV mass between
the first and second scan, examined in a subsample, were
0.94 and 0.82, respectively. The intrareader correlation for
LV mass was 0.98 [20].
Alterations in LV geometry were assessed by several
approaches. Relative wall thickness (RWT) was calculated
as the sum of wall thicknesses (septum + diastolic poste-
rior wall thickness) divided by LV diastolic diameter, with
elevated RWT defined as greater or equal to 0.45 [21]; In
multivariate analysis increased LV diameter was defined
as the upper quartile of gender specific left ventricular
diameter. To define increased wall thickness for mode-
ling, we used the median as cut-off point for the sum of
wall thicknesses, as about two-thirds of both men and
women in the sample had a RWT above 0.45.
We investigated the differences in crude prevalences
between groups in stratified analyses with Chi-square sta-
tistics. We used logistic regression analysis (SAS 8.0 Soft-
ware, Cary, NC) to study the independent association of
variables with pre-defined echocardiographic features.
Associations were adjusted for adiposity by including
obesity, defined by BMI, and waist-hip ratio in models.
For further, in multiple adjustment, we added the covari-
ates age, systolic blood pressure, antihypertensive medica-
tion use, total cholesterol, activity level, smoking and
education level. Height was also included as a covariate in
analyses of increased LV diameter and increased wall
thickness. In these multivariable models, we used clini-
cally defined cut-points, when present, for continuous
exposure variables. In order to produce exposure frequen-
cies similar to that of diabetes, we modeled variables with-
out pre-defined cut-points comparing the upper quartilePage 2 of 8
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the Wald statistic of the gender interaction term. We
employed the variance inflation factor to identify colline-
arity among variables measuring potentially similar bio-
logical effects. The variance inflation factor was never
greater than 3.0, suggesting that important collinearity
was absent [22].
Results
The 1479 individuals included in the study differed some-
what from the 955 subjects undergoing the exam but
excluded from these analyses. The included participants
had a similar gender distribution, somewhat lower preva-
lences of diabetes (22% vs. 25%; P = 0.22) and obesity
(45% vs. 49%; P = 0.07), and less hypertension (57% vs.
64%; P = 0.02) than those excluded.
Of those studied, 514 (35%) were men and 965 (65%)
were women. Compared with men, women had consider-
ably higher prevalences of diabetes, obesity and hyperten-
sion (Table 1). Unindexed LV mass was higher with
diabetes in both men (238.3 ± 79.4 g vs. 213.7 ± 58.6 g; p
< 0.001) and women (206.4 ± 61.5 g vs. 176.9 ± 50.1 g; p
< 0.001), as was height-indexed LV mass (men:52.4 ± 18.1
g/m2.7 vs. 46.5 ± 13.2 g/m2.7, p < 0.01; women:55.2 ± 17.0
g/m2.7 vs. 47.2 ± 13.5 g/m2.7, p = 0.001).
LVH was a common finding, but the prevalence and sex
differences in LVH varied depending on the indexation
criteria used (Table 2). Compared with men, women had
a higher prevalence of unindexed LVH, and of height
indexed, but not BSA indexed LVH. Prevalence of
increased RWT was similar in men and women.
The unadjusted height-indexed LVH prevalences were
higher in those with diabetes (52% vs. 32%; p < 0.001),
obesity (55% vs. 22%; p < 0.001), and hypertension (48%
vs. 21%; p < 0.001). Prevalences of increased RWT were
also greater in those with diabetes (73% vs. 64%; P =
0.002) and hypertension (70% vs. 60%; P < 0.001), but
not so in those classified as obese (68% vs. 64%; P =
0.07). However, sex-specific analyses showed that differ-
ences in prevalences of height-adjusted LVH associated
with diabetes were similar in men and women, but the
higher prevalence of increased RWT with diabetes was
seen only in women (Figure 1; P < 0.01).
In sex-adjusted analyses, those with diabetes had a more
than two-fold greater frequency of LVH (Table 3). Adjust-
ing also for body mass index and waist-hip ratio reduced
the magnitude of this association. Multiple adjustment,
including also other relevant covariates, as described in
the table footnotes, caused only a small further attenua-
tion of this association (Table 3). Of note, in these mod-
els, is the relatively small size of the diabetes association,
in comparison, in the same model, with that of obesity
(OR = 3.63 95%CI 2.80–4.72), and the upper quartiles of
waist-hip ratio (1.55 95%CI 1.17–2.06) and of systolic
blood pressure (OR = 3.41 95%CI 2.59–4.48). Multiply-
adjusted gender-specific associations were roughly similar
in men (OR = 1.41 95%CI 0.83–2.41) and in women (OR
= 1.50 95%CI 1.05–2.14).
The unadjusted association of diabetes with relative wall
thickness differed notably between men (OR = 0.84
95%CI 0.53–1.32) and women (OR = 2.06 95%CI 1.46–
2.91; interaction P = 0.002). Multiply-adjusted gender-
specific analyses revealed that diabetes was associated
with increased RWT in women (OR = 1.63 95%CI 1.12–
2.37) but not in men (OR = 0.64 95%CI 0.39–1.04).
Gender differences in RWT response were additionally
investigated evaluating the RWT components – increased
LV diameter and sum of wall thicknesses (Table 4). Multi-
ply-adjusted gender-specific analysis showed that, in
women, diabetes was not associated with larger LV cham-
ber diameter (OR = 1.02 95%CI 0.70–1.48), but was with
wall thickness (OR = 1.88 95%CI 1.34–2.65). In contra-
Table 1: Participant characteristics by gender
Men (N = 514) Women (N = 965)
Age – years 58.4 (5.8) 58.6 (5.6)
Diabetes (%) 98 (19%) 232 (24%)†
Obesity (%) 152 (30%) 509 (53%)§
Hypertension (%) 275 (53%) 576 (60%)†
Height – m 1.76 (0.07) 1.63 (0.06)§
Body Mass Index – kg/m2 28.1 (4.8) 31.2 (6.2)§
Systolic Blood Pressure – mmHg 130 (20) 131 (20)
Glucose – mg/dL 120 (57) 122 (56)
Smokers (%) 139 (27%) 145 (15%)§
Metabolic Syndrome|| (%) 185 (36%) 501 (52%)§
Expressed as N (%) or mean (standard deviation);
P values testing the difference between genders: † <0.05; ‡ <0.01; § <0.001;
|| Adapted from NCEP criteria [37].Page 3 of 8
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larger LV chamber size (OR = 2.13 95%CI 1.28–3.53), in
men, but not so with wall thickness (OR = 1.33 95%CI
0.81–2.18). In women, greater BMI was associated with
both greater LV diameter (4th quartile vs. the rest, OR =
3.43 95%CI 2.42–4.87) and wall thickness (OR = 1.68
95%CI 1.27–2.23); in men, with greater wall thickness
(OR = 2.58 95%CI 1.63–4.07).
Discussion
Consistent with previous reports [8,9], LV structural
abnormalities were frequent in this community sample of
African-Americans. The prevalence of left ventricular
hypertrophy was particularly high in women, even after
body size adjustments. Within this context, we found an
association of diabetes with LVH which, though dimin-
ishing with adjustment for obesity indices, was independ-
ent of body size. The association of LV structural
abnormalities with diabetes [2], as well as with impaired
glucose tolerance [23] in our African American cohort, is
consistent with previous studies in predominantly or
exclusively white cohorts.
Employment of relative wall thickness to evaluate geo-
metric remodeling resulted in an unanticipated finding.
Whereas RWT prevalences were similar between men and
women, diabetes was associated with increased RWT in
women; in men, if anything, with the reverse. Separate
evaluation of the components of relative wall thickness –
ventricular chamber size and wall thickness – produced a
possible explanation for the apparent paradox: In women
diabetes was associated with increased wall thickness, but
not with increased left ventricular diameter. In men, on
the contrary, diabetes was more strongly associated with
increased left ventricular diameter than with increased
wall thickness. This finding demonstrates a potential lim-
itation of using the ratio of these two measures to identify
the structural changes related to diabetes.
Differences in correlates of left ventricular structure may
indicate that the pathophysiologic mechanisms leading to
heart maladaptive response differ somewhat between gen-
ders. Females have been found to have an increased wall
thickness response to pressure overload compared with
males in clinical [13] and in animal studies [24]. These
gender-specific differences in the impact of carbohydrate
metabolism has also been identified in patients with the
metabolic syndrome [25], but has been scarcely investi-
gated in African-Americans. In non-diabetic American
Indians of the Strong Heart Study [26] fasting insulin lev-
els were associated with LV mass in men and with wall
thickness in women. In the Framingham Study cohorts
[1], increased LV mass and RWT were seen in diabetic
women but not diabetic men. More recent analysis from
the Framingham Heart Study [27], showed an increase in
RWT parallel to diabetes severity and to insulin resistance
(homeostasis model, HOMA-IR) only in women,
although most of this association appeared to be
explained by obesity. It is important to note that adjust-
ment for indices of adiposity appeared to account for
most of the reduction in the magnitude of diabetes asso-
ciations seen in multiply-adjusted models. This finding
was suggested by Galvan et al.[28], and is consistent with
a recent review that concluded that associations of insulin
and glucose metabolism with LV mass were mostly
explained by adiposity [29]. In fact, one of the largest
studies to date, the HyperGEN Study, with adequate rep-
resentation of African-Americans, found inverse associa-
Table 2: Echocardiographic measurements and prevalences of structural abnormalities in men and women*
Men (N = 514) Women (N = 965)
Echocardiographic Measurements
Left Ventricular Diameter Diastole – mm 47.6 (5.7) 45.1 (5.4)§
Septum Thickness – mm 11.9 (2.5) 11.2 (2.2)§
Posterior Wall Thickness – mm 12.0 (2.2) 11.2 (1.9)§
Relative Wall Thickness (RWT) 0.51 (0.13) 0.50 (0.11)
Fractional Shortening (%) 37.0 (7.3) 40. (7.5)§
Left Ventricular Mass Estimates||
LV mass – g 218.4 (63.8) 184.0 (54.6)§
LV mass/BSA – g/m2 107.2 (29.7) 97.3 (25.7)§
LV mass/Height2.7 – g/m2.7 47.6 (14.4) 49.1 (14.8)†
Structural Abnormalities
Unindexed LVH (38) 59 (11.5%) 339 (35.1%)§
Height2.7 – Indexed LVH 169 (32.9%) 373 (38.6%)†
Relative Wall Thickness >= 0.45 332 (64.6%) 645 (66.8%)
*Expressed as N (%) or mean (standard deviation);
P values testing the difference between genders: † <0.05; ‡ <0.01; § <0.001;
||According to Devereux Modified Formula;
LV = Left Ventricular; BSA = Body Surface Area; LVH = LV HypertrophyPage 4 of 8
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Prevalences of structural abnormalities. Prevalences of left ventricular hypertrophy and increased relative wall thickness 
in African-Americans with diabetes (black columns) and without diabetes (grey columns); P values diabetes vs. no diabetes: † 
<0.05; ‡ <0.01; § <0.001; NS non significant.
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Table 3: Crude and adjusted associations of diabetes with height-indexed left ventricular hypertrophy (LVH2.7)
OR (95%CI)
Unadjusted
Diabetes 2.29 (1.78–2.94)
Adiposity Adjusted*
Diabetes 1.60 (1.22–2.10)
Multiply Adjusted†
Diabetes 1.49 (1.12–2.00)
Gender (Male) 0.95 (0.72–1.26)
Obesity (BMI) 3.63 (2.80–4.72)
Waist-Hip Ratio‡ 1.55 (1.17–2.06)
Systolic BP‡ 3.41 (2.59–4.48)
* Model adjusted for gender, BMI and waist-hip ratio;
† Model adjusted for gender, BMI, waist-hip ratio, systolic blood pressure, age, total cholesterol, activity level, smoking, education level and 
antihypertensive medication use;
‡ 4th Quartile vs. rest of sample;Page 5 of 8
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insulin resistance syndrome was performed [30]. Moreo-
ver, another analysis from the ARIC African-American par-
ticipants showed greater interventricular and septal wall
thicknesses in the obese, independent of blood pressure
levels and diabetes [10].
The traditional explanation for the important association
of obesity with abnormal LV responses is that obesity pro-
duces a hemodynamic stress, with increased heart rate,
blood volume, and blood pressure [31]. However, recent
recognition of the inflammatory state present in obesity,
believed to be in large part mediated by adipocyte secre-
tory products and which may underlie insulin resistance
[32], has changed our understanding of the pathophysio-
logic links of obesity with diabetes and cardiovascular dis-
eases [32]. Moreover, many of these immune-
inflammatory mediators may have important roles in ven-
tricular remodeling [33] and heart failure [34]. The fre-
quently large associations seen here with adiposity indices
and the important reduction in diabetes associations seen
with adjustment for these indices provides epidemiologic
evidence supporting the hypothesis that these processes
are indeed active in the pathophysiology of ventricular
dysfunction.
There are, however, additional specific mechanisms by
which diabetes might be related to LV geometry and
hypertrophy. Diabetes may contribute to ventricular
adaptive changes through an increase in pro-inflamma-
tory immune mediators resulting from the oxidative stress
caused by hyperglycemia [32,35]. The association may
also be mediated through the production of advanced gly-
cation end products (AGE), which may, by leading to a
reduced degradation of collagen, impair ventricular com-
pliance [36].
Some limitations to our study merit mention. Forty per-
cent of the initially enrolled participants could not be ana-
lyzed, creating the possibility of selection bias influencing
our results. In this regard, as those included were generally
healthier than those excluded, and the associations we
have demonstrated may underestimate the true associa-
tion between diabetes and LVH. The high prevalence of
obesity makes these results of questionable generalizabil-
ity to leaner populations. Finally, the high prevalence of
examined echocardiographic features results in the
reported odds ratios being overestimates of relative risk.
Conclusion
In conclusion, diabetes is associated with increased LVH
in middle-aged and elderly African-American men and
women. Most of this increase appears to be more closely
associated with obesity, especially central obesity, than to
diabetes per se. Diabetes associated altered ventricular
structure appears to differ by gender. This may be due to
gender difference in the cardiac response to the patho-
physiologic factors underlying LV morphology – in men
the process of increased mass being more coupled with
chamber dilation whereas in women expressed mostly as
wall thickening. The gender difference in LV structure
complicates the use of common geometric patterns defini-
tions when comparing ventricular remodeling in response
to diabetes.
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Table 4: Crude and adjusted gender-specific associations of diabetes with increased left ventricular diameter and wall thickness
Left Ventricular Diameter Wall Thickness
Men Women Men Women
OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Unadjusted
Diabetes 2.36 (1.48–3.77) 1.31 (0.94–1.82) 1.77 (1.13–2.79) 2.70 (1.97–3.68)
Body-size Adjusted*
Diabetes 2.10 (1.30–3.41) 1.01 (0.71–1.44) 1.48 (0.93–2.37) 2.04 (1.47–2.84)
Multiply Adjusted†
Diabetes 2.13 (1.28–3.53) 1.02 (0.70–1.49) 1.33 (0.81–2.18) 1.89 (1.34–2.66)
BMI‡ 1.22 (0.75–2.00) 3.43 (2.42–4.87) 2.58 (1.63–4.07) 1.68 (1.27–2.23)
Waist-Hip Ratio‡ 1.50 (0.90–2.50) 0.88 (0.61–1.27) 1.09 (0.68–1.76) 1.85 (1.32–2.58)
Systolic BP‡ 1.85 (1.16–2.96) 2.04 (1.44–2.89) 2.24 (1.43–3.52) 2.00 (1.44–2.79)
* Models adjusted for BMI, waist-hip ratio and height;
† Models adjusted for BMI, waist-hip ratio, systolic blood pressure, height, age, total cholesterol, activity level, smoking, education level and 
antihypertensive medication use;
‡ 4th Quartile vs. rest of sample;Page 6 of 8
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